This study will describe and compare the rates of asthma exacerbations observed between 12-month pre-switch and 12-month post-switch periods among participants switching to AIRSUPRA. Other outcome measures included in this study are asthma-related oral corticosteroid (OCS) use, and asthma exacerbation-related healthcare resource utilization (HCRU), healthcare cost, and patient reported outcomes (PROs).
Patient Stories
April 7, 2023
Peter DeLorey has been in many golf tournaments over the years but a two-day event this spring was particularly special. It was the first one he has done with his son, and it’s something he couldn’t have done at all a year ago.